Dividend
-
-
-
-
-
-
-
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical
-
-
-
-
-
-
-
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease
-
-
-
-
-
-
-
Algoma Central Corporation Reports Financial Results for the 2024 Second Quarter
-
-
-
-
-
-
-
Algoma Central Corporation Reports Financial Results for Fiscal 2023
-
-
-
-
-
-
-
Alcon Announces Results of 2023 Annual General Meeting
-
-
-
-
-
-
-
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
-
-
-
-
-
-
-
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

